Evaluation of a Novel Web-Based Prior Approval Application for Palivizumab Prophylaxis of Respiratory Syncytial Virus in a State Medicaid Program

BACKGROUND: Recent disproportionate increases in use of specialty medications, such as palivizumab (Synagis), compared with steady utilization of traditional medication use, have prompted complex utilization management strategies that require frequent evaluation to facilitate cost-effectiveness whil...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundeen, Kristin, Pfeiffenberger, Trista, Vann, Julie Jacobson, O’Brien, Timothy, Sampson, Charlene, Wegner, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437901/
https://www.ncbi.nlm.nih.gov/pubmed/23461427
http://dx.doi.org/10.18553/jmcp.2013.19.2.115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437901/
https://www.ncbi.nlm.nih.gov/pubmed/23461427
http://dx.doi.org/10.18553/jmcp.2013.19.2.115

Ejemplares similares